Skip to main content
. 2022 Jan 24;148(5):1045–1055. doi: 10.1007/s00432-021-03854-6

Table 1.

Individual patient characteristics and summary

# MM subtype BM infiltration CG Age (yrs) Gender Status ISS Comment
1 IgA kappa 80% HR 69 Female RRMM 1 MM
2 IgG kappa 80% HR 70 Male RRMM 2 MM
3 kappa-LC 80% HR 52 Male RRMM 1 PCL
4 IgG kappa 80% HR 83 Male ID 3 MM
5 IgA kappa 90% HR 66 Male RRMM 3 MM
6 IgG kappa 90% HR 51 Male ID 3 MM
Σ median (range) IgG (n = 3) 80% (80–90%) HR (n = 6) 68 (51–83) Female (n = 1) RRMM (n = 6) 1 (n = 2) MM (n = 5)
IgA (n = 2) Male (n = 5) ID (n = 2) 2 (n = 1) PCL (n = 1)
kappa-LC (n = 1) 3 (n = 3)

MM multiple myeloma, RRMM relapsed/refractory MM, ID initial diagnosis, PCL plasma cell leukemia, EM-MM extramedullary MM, CG cytogenetics, HR unfavorable cytogenetics defined as deletion 17p, t(4;14), t(14;16), t(14;20) or gain 1q